Analysts Viewpoint
SGMT stock rated a Buy by H.C. Wainwright
Sagimet Biosciences Inc’s filing revealed that its President & CEO Happel David acquired Company’s shares for reported $63731.0 on Mar
Menu
Sagimet Biosciences Inc’s filing revealed that its President & CEO Happel David acquired Company’s shares for reported $63731.0 on Mar
In a filing, Sagimet Biosciences Inc revealed its President & CEO Happel David acquired Company’s shares for reported $63731.0 on
Sagimet Biosciences Inc’s filing revealed that its President & CEO Happel David acquired Company’s shares for reported $63731.0 on Mar